Damage from concussions and the progressive deterioration of neurons in Alzheimer’s look similar on brain scans, according to the latest study, and produce similar symptoms as well. In studying a group of concussions patients to determine...Show More Summary
NitroMemantine is the first drug to halt the progression of synaptic loss and to even restore these connections between nerve cells. The combination drug is now headed for clinical trials.
Multiple drug classes commonly prescribed for common medical conditions are capable of influencing the onset and progression of Alzheimer’s disease. +Alzheimer's Reading Room Multiple drug classes commonly prescribed for common medical...Show More Summary
Multiple drug classes commonly prescribed for common medical conditions are capable of influencing the onset and progression of Alzheimer's disease.
Alzheimer's disease is an irreversible, progressive brain disease. It is characterized by the development of amyloid plaques and neurofibrillary tangles, the loss of connections between nerve cells, or neurons, in the brain, and the death of these nerve cells. Show More Summary
Highly educated individuals with mild cognitive impairment that later progressed to Alzheimer's disease cope better with the disease than individuals with a lower level of education in the same situation, according to a new study. In...Show More Summary
Few diseases have frustrated researchers like Alzheimer's disease. First identified in 1906, the disease still has no cure and strikingly little real progress in helping patients. Is there any hope for light at the end of this long, dark tunnel? Dead endsThe history of dead ends in Alzheimer's research isn't encouraging. Show More Summary
County music legend Glen Campbell’s struggle with Alzheimer’s has forced him to stop touring. The musician’s wife and his managers stated that the disease has progressed to the point that he can now longer tour in support of his work. Campbell wrapped up his “Goodbye Tour” towards the end of last year. While his days [...]Show More Summary
The Seven Stages of Alzheimer's describes patterns of symptom progression that typically occur in individuals with living with Alzheimer’s disease. What is Alzheimer's Disease It is important to note that not everyone living with Alzheimer's or a related dementia will experience the same symptoms or progress at the same rate over time. Show More Summary
A new study from researchers at the University of Florida may have uncovered a critical factor that drives the relentless progression of Alzheimer's disease - a discovery that could eventually slow its progression. For more than 15 years,...Show More Summary
For years I felt like I was being treated like the little boy who cried wolf. Well, we beat the wolf called Alzheimer's and so can you. By Bob DeMarco Alzheimer's Reading Room In 2004, I made my first important decision as an Alzheimer's...Show More Summary
The plaque deposits in the brain of Alzheimer's patients are surrounded by the brain's own immune cells, the microglia. This was already recognized by Alois Alzheimer more than one hundred years ago. But until today it still remains unclear what role microglia play in Alzheimer's disease. Show More Summary
The plaque deposits in the brain of Alzheimer's patients are surrounded by the brain's own immune cells, the microglia. But it still remains unclear what role microglia play in Alzheimer's disease. Do they help break down the plaque deposit?
by Doug Allen David Hilfiker, diagnosed with a “progressive cognitive impairment” which is “almost certainly Alzheimer’s” in September 2012, is blogging the deterioration of his capacities: Friday I decided to walk the family dog and join my grandchildren at the nearby park. The dog sometimes slips out of her collar and needs a simple harness to keep [...]
Alzheimer’s disease is linked to the formation of protein plaques in the brain, but how these plaques form is still not clear. A new study has found key genetic markers that are linked to plaque formation and disease progression, and regulate the levels of the proteins that aggregate into plaques. People who have a buildup... [Continue Reading]
From a story in today's Washington Post:At the time, he dismissed the incident as a bizarre memory lapse, perhaps a byproduct of his age, then 66. But now, two and a half years later, he recognizes it for what it was: one of the first major signs of his mind’s decline. Show More Summary
Navidea Biopharmaceuticals Announces Enrollment of First Subject in Phase 2b Trial of NAV4694 in Subjects with Mild Cognitive Impairment (MCI) - Study to evaluate NAV4694 in monitoring progression of MCI to Alzheimer's Disease - DUBLIN, Ohio--(BUSINESS WIRE)-- Navidea Biopharmaceuticals, Inc. Show More Summary
Experimental drug treatments promising to slow or reverse the progression of Alzheimer's disease will need to be assessed with a new and more subtle set of rules, a pair of FDA officials wrote this week. The resulting new guidelines, predict some researchers, should allow Alzheimer's drugs under development to travel a faster path to the U.S. Show More Summary
An anti-atherosclerosis drug greatly reduced blood-brain barrier (BBB) leaks in animal models with diabetes and hypercholesterolemia and linked BBB permeability with amyloid peptide deposits at the site of early Alzheimer's patholog...